In 2023, China led global exports of cortisone-related products with diminishing returns of 0.58%, followed distantly by Italy and the United States, both showing mixed performance with slight changes. Notably, India experienced a significant rise of 6.73%, indicating a potential growth trend. Conversely, Belgium, Germany, and Singapore faced substantial declines, highlighting a shifting market landscape. Emerging players like South Africa and Peru demonstrated robust y-o-y growth, albeit from a smaller base. The past five years reveal a fluctuating market influenced by economic factors and pharmaceutical innovations.
Future trends to monitor include India's continued ascent as a major exporter due to its expanding pharmaceutical sector and competitive pricing. Additionally, the sustained growth of smaller countries like South Africa may reshape market dynamics, especially if these regions attract further investment in pharmaceutical manufacturing capabilities. Expanding regulatory expectations and evolving health care needs will continue to drive export quantities and preferences globally.
Top countries in Export of Cortisone, Hydrocortisone, Prednisone and Prednisolone by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 129,350,000 | 2023 | +0.087% | -0.58% | View data |
| 2 | 2 Italy | 20,892,000 | 2023 | -1.12% | +1.52% | View data |
| 3 | 3 United States | 19,421,000 | 2023 | -4.31% | -4.08% | View data |
| 4 | 4 Spain | 16,165,000 | 2023 | -0.89% | +3.08% | View data |
| 5 | 5 India | 7,720,300 | 2023 | -1.16% | +6.73% | View data |
| 6 | 6 Belgium | 5,348,000 | 2023 | -9.18% | -5.73% | View data |
| 7 | 7 Germany | 1,802,600 | 2023 | -21.4% | -17.07% | View data |
| 8 | 8 Singapore | 1,426,500 | 2023 | -25.37% | -20.55% | View data |
| 9 | 9 Hungary | 1,222,000 | 2023 | +4.53% | +2.96% | View data |
| 10 | 10 United Kingdom | 1,182,200 | 2023 | +0.44% | +0.26% | View data |
